As of Jul 31
| +1.06 / +7.43%|
The 5 analysts offering 12-month price forecasts for Theravance Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a -2.09% decrease from the last price of 15.32.
The current consensus among 6 polled investment analysts is to Hold stock in Theravance Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.